Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.89.
Market Cap
10T
Revenue
4.74T
Profits
213.33B
PE Ratio
46.89
Profit Margin
4.50%
Dividend Yield
0.38%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.28T | -0.82% | 3,209,224 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 680.19B | -1.12% | 8,404,369 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 520.65B | -0.16% | 5,493,799 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 369.18B | 1.12% | 4,428,648 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 356.13B | -2.23% | 8,650,872 | 67.38B |
| 6 | NVS | Novartis AG | 305.45B | -0.19% | 1,630,493 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 287.09B | -0.23% | 1,951,685 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.15B | -1.27% | 1,606,434 | 47.35B |
| 9 | AMGN | Amgen Inc. | 250.07B | -0.72% | 1,925,829 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.86B | -0.30% | 4,605,017 | 30.99B |
| 11 | ABT | Abbott Laboratories | 186.10B | -0.99% | 8,809,057 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 185.23B | -0.07% | 17,067,282 | 50.70B |
| 13 | PFE | Pfizer Inc. | 164.50B | -0.10% | 40,153,147 | 63.62B |
| 14 | DHR | Danaher Corporation | 161.75B | -1.33% | 3,233,237 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.74B | -1.32% | 1,824,720 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 136.35B | -0.15% | 1,224,595 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.63B | -0.79% | 9,999,368 | 50.03B |
| 18 | MCK | McKesson Corporation | 127.58B | 0.20% | 900,052 | 418.79B |
| 19 | MDT | Medtronic plc | 125.94B | 0.02% | 6,804,776 | 37.54B |
| 20 | SYK | Stryker Corporation | 118.29B | 0.35% | 2,479,602 | 26.30B |
| 21 | SNY | Sanofi | 116.47B | 0.04% | 2,272,023 | 57.89B |
| 22 | CVS | CVS Health Corporation | 113.35B | -0.85% | 11,780,848 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 106.91B | 2.55% | 1,055,134 | 78.70B |
| 24 | GSK | GSK plc | 101.94B | -0.08% | 2,946,082 | 44.53B |
| 25 | ELV | Elevance Health, Inc. | 96.42B | 3.86% | 2,280,453 | 201.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 95.57B | -0.32% | 700,840 | 16.90B |
| 27 | MRNA | Moderna, Inc. | 87.10B | -3.63% | 7,023,752 | 2.53B |
| 28 | CI | The Cigna Group | 79.09B | 1.06% | 1,328,682 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.95B | 0.75% | 3,259,612 | 29.86B |
| 30 | COR | Cencora, Inc. | 68.11B | -0.58% | 1,214,670 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 65.61B | 0.98% | 1,508,945 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 63.33B | -1.47% | 16,109,232 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 61.59B | -0.04% | 4,544,589 | 6.67B |
| 34 | ARGX | argenx SE | 59.84B | -0.95% | 303,579 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.96B | -0.72% | 1,498,405 | 19.46B |
| 36 | HUM | Humana Inc. | 55.40B | 2.50% | 1,306,119 | 154.19B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 55.20B | -0.51% | 491,001 | 4.66B |
| 38 | MDLN | Medline Inc. | 51.52B | -0.76% | 7,542,854 | 30.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.67B | -4.34% | 7,461,277 | 17.23B |
| 40 | A | Agilent Technologies, Inc. | 48.75B | -0.60% | 1,825,513 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 48.46B | -0.75% | 1,105,672 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 46.98B | -1.26% | 159,162 | 6.45B |
| 43 | WAT | Waters Corporation | 44.56B | -1.48% | 575,428 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 43.63B | -0.15% | 1,539,099 | 17.31B |
| 45 | NTRA | Natera, Inc. | 41.83B | -9.59% | 2,335,218 | 2.91B |
| 46 | HLN | Haleon plc | 40.20B | 0.33% | 16,089,124 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.31B | -1.13% | 3,044,130 | 2.62B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 37.51B | -0.07% | 3,485,489 | 21.64B |
| 49 | BIIB | Biogen Inc. | 37.20B | -0.69% | 839,703 | 10.30B |
| 50 | CNC | Centene Corporation | 37.02B | 4.91% | 8,474,778 | 180.41B |
| 51 | RVMD | Revolution Medicines, Inc. | 36.09B | -3.15% | 2,553,347 | 197.56M |
| 52 | ALC | Alcon Inc. | 35.56B | -0.65% | 1,768,816 | 10.98B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.36B | -0.67% | 146,641 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 34.29B | 0.68% | 4,088,843 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.50B | -0.56% | 1,049,465 | 5.73B |
| 56 | GMAB | Genmab A/S | 32.90B | 0.39% | 2,407,812 | 4.30B |
| 57 | DXCM | DexCom, Inc. | 30.44B | -2.06% | 4,375,465 | 5.10B |
| 58 | LH | Labcorp Holdings Inc. | 30.24B | 0.53% | 509,101 | 14.59B |
| 59 | ILMN | Illumina, Inc. | 29.94B | -4.35% | 1,519,220 | 4.54B |
| 60 | PHG | Koninklijke Philips N.V. | 29.64B | -0.66% | 1,170,023 | 20.16B |
| 61 | WST | West Pharmaceutical Services, Inc. | 29.10B | 0.33% | 526,157 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.85B | 1.01% | 734,852 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 27.98B | -2.33% | 8,730,715 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.96B | 1.42% | 2,233,033 | 1.52B |
| 65 | STE | STERIS plc | 25.43B | -0.91% | 934,201 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 25.04B | -0.56% | 441,674 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.51B | -0.58% | 1,510,375 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.78B | -0.38% | 7,139,284 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.20B | 1.93% | 599,456 | 22.15B |
| 70 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.39B | -3.22% | 2,164,849 | 5.01B |
| 71 | BNTX | BioNTech SE | 21.14B | -0.40% | 1,036,184 | 2.75B |
| 72 | GH | Guardant Health, Inc. | 19.49B | -5.06% | 2,116,478 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.19B | -1.74% | 3,135,783 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.13B | -0.88% | 226,126 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 17.82B | -1.33% | 870,212 | 1.37B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.73B | -1.25% | 1,386,045 | 3.70B |
| 77 | RVTY | Revvity, Inc. | 16.62B | -3.59% | 1,480,366 | 2.94B |
| 78 | EXEL | Exelixis, Inc. | 16.37B | -2.75% | 2,683,673 | 2.50B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.08B | -0.72% | 693,841 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.39B | -0.74% | 490,227 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.07B | -1.20% | 1,347,295 | 945.54M |
| 82 | SOLV | Solventum Corporation | 15.05B | -0.48% | 848,107 | 8.16B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 14.87B | 0.22% | 3,101,248 | 15.25B |
| 84 | GKOS | Glaukos Corporation | 14.49B | -0.34% | 865,433 | 690.33M |
| 85 | ICLR | ICON Public Limited Company | 14.34B | -1.67% | 826,218 | 8.23B |
| 86 | EHC | Encompass Health Corporation | 13.94B | 0.79% | 678,451 | 6.34B |
| 87 | BAX | Baxter International Inc. | 13.21B | -1.05% | 6,159,844 | 11.61B |
| 88 | ELAN | Elanco Animal Health Incorporated | 13.20B | -1.38% | 4,084,660 | 5.15B |
| 89 | SNN | Smith & Nephew plc | 12.98B | -0.99% | 1,274,715 | 6.30B |
| 90 | PEN | Penumbra, Inc. | 12.64B | -0.09% | 250,380 | 1.56B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 12.21B | -0.27% | 1,232,009 | 3.44B |
| 92 | MOH | Molina Healthcare, Inc. | 12.14B | 11.27% | 1,774,210 | 42.08B |
| 93 | MTRI | Mentari Therapeutics, Inc. | 11.95B | 6.83% | 11,658 | - |
| 94 | TEM | Tempus AI, Inc. | 11.81B | -9.55% | 5,071,062 | 1.51B |
| 95 | COO | The Cooper Companies, Inc. | 11.77B | -1.23% | 1,835,208 | 4.24B |
| 96 | ALGN | Align Technology, Inc. | 11.70B | -1.39% | 904,186 | 4.16B |
| 97 | TECH | Bio-Techne Corporation | 11.43B | -0.01% | 3,502,601 | 1.23B |
| 98 | UHS | Universal Health Services, Inc. | 11.40B | 1.92% | 774,090 | 18.35B |
| 99 | FMS | Fresenius Medical Care AG | 11.29B | -0.77% | 1,494,546 | 22.12B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 11.23B | 1.33% | 2,020,680 | 3.66B |
| 101 | HALO | Halozyme Therapeutics, Inc. | 11.00B | -3.76% | 2,088,288 | 1.80B |
| 102 | DVA | DaVita Inc. | 10.96B | -0.19% | 531,874 | 14.17B |
| 103 | ENSG | The Ensign Group, Inc. | 10.89B | -0.10% | 267,700 | 5.67B |
| 104 | KYMR | Kymera Therapeutics, Inc. | 10.74B | -1.35% | 912,473 | 102.24M |
| 105 | RGEN | Repligen Corporation | 10.41B | -2.99% | 575,425 | 805.61M |
| 106 | AVTR | Avantor, Inc. | 10.38B | -1.42% | 6,146,345 | 6.64B |
| 107 | QGEN | Qiagen N.V. | 10.29B | -0.16% | 1,716,427 | 2.12B |
| 108 | PODD | Insulet Corporation | 10.08B | -4.72% | 1,975,174 | 3.19B |
| 109 | HNGE | Hinge Health, Inc. | 9.86B | 5.11% | 2,079,777 | 800.82M |
| 110 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.85B | -0.80% | 493,606 | 1.43B |
| 111 | PCVX | Vaxcyte, Inc. | 9.75B | -2.78% | 707,760 | - |
| 112 | OSCR | Oscar Health, Inc. | 9.72B | 0.90% | 5,684,353 | 17.47B |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.69B | -1.67% | 169,935 | 2.59B |
| 114 | SMMT | Summit Therapeutics Inc. | 9.45B | -16.47% | 24,445,720 | - |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.44B | -4.45% | 824,688 | - |
| 116 | HSIC | Henry Schein, Inc. | 9.39B | -1.46% | 1,711,230 | 13.73B |
| 117 | GMED | Globus Medical, Inc. | 9.34B | -2.27% | 1,375,322 | 3.14B |
| 118 | BRKR | Bruker Corporation | 9.26B | -1.57% | 2,645,306 | 3.51B |
| 119 | ATR | AptarGroup, Inc. | 9.08B | 0.06% | 681,214 | 3.99B |
| 120 | KRYS | Krystal Biotech, Inc. | 8.83B | -2.40% | 203,283 | 470.03M |
| 121 | TGTX | TG Therapeutics, Inc. | 8.79B | -2.71% | 1,731,471 | 897.76M |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.67B | -5.44% | 668,041 | 7.46M |
| 123 | HQY | HealthEquity, Inc. | 8.65B | 1.08% | 860,317 | 1.36B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.15B | -4.67% | 565,185 | 551.69M |
| 125 | ALKS | Alkermes plc | 7.82B | -1.06% | 1,051,959 | 1.75B |
| 126 | PACS | PACS Group, Inc. | 7.78B | 1.41% | 489,654 | 5.71B |
| 127 | GRFS | Grifols, S.A. | 7.65B | 0.46% | 441,042 | 8.63B |
| 128 | CORT | Corcept Therapeutics Incorporated | 7.58B | -5.10% | 1,097,640 | 963.65M |
| 129 | CGON | CG Oncology, Inc. | 7.57B | 13.95% | 9,881,594 | 6.17M |
| 130 | BLCO | Bausch + Lomb Corporation | 7.46B | -1.00% | 729,716 | 5.42B |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.45B | -6.56% | 964,694 | 280.75M |
| 132 | CYTK | Cytokinetics, Incorporated | 7.41B | -5.27% | 1,756,305 | 113.29M |
| 133 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.40B | -2.18% | 455,207 | 945.96M |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.40B | -0.70% | 1,684,697 | 3.20B |
| 135 | TXG | 10x Genomics, Inc. | 7.23B | -5.50% | 3,180,070 | 618.58M |
| 136 | AXSM | Axsome Therapeutics, Inc. | 7.21B | -3.30% | 989,279 | 865.27M |
| 137 | CHE | Chemed Corporation | 7.12B | 0.36% | 168,437 | 2.66B |
| 138 | ABVX | ABIVAX Société Anonyme | 7.04B | -4.53% | 840,132 | 5.33M |
| 139 | IMVT | Immunovant, Inc. | 6.89B | -2.63% | 1,053,958 | - |
| 140 | ORKA | Oruka Therapeutics, Inc. | 6.73B | -5.80% | 989,987 | - |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.65B | 0.13% | 583,139 | 1.56B |
| 142 | TWST | Twist Bioscience Corporation | 6.59B | -5.88% | 2,574,419 | 459.43M |
| 143 | KOD | Kodiak Sciences Inc. | 6.57B | -9.41% | 980,376 | - |
| 144 | BLTE | Belite Bio, Inc | 6.55B | -1.10% | 191,270 | - |
| 145 | IBRX | ImmunityBio, Inc. | 6.36B | -0.66% | 12,804,953 | 182.57M |
| 146 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.25B | -7.47% | 1,863,749 | 450.82M |
| 147 | TFX | Teleflex Incorporated | 6.23B | 1.51% | 799,562 | 2.26B |
| 148 | RDNT | RadNet, Inc. | 6.06B | 0.62% | 565,017 | 2.38B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | -2.29% | 191,247 | 253.83M |
| 150 | CAI | Caris Life Sciences, Inc. | 6.02B | -8.85% | 3,701,689 | 1.05B |
| 151 | SUPN | Supernus, Inc. | 5.99B | -2.99% | 3,898,280 | 1.37B |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 5.98B | -2.56% | 506,487 | 670.78M |
| 153 | DOCS | Doximity, Inc. | 5.85B | -1.71% | 1,805,967 | 661.58M |
| 154 | HAE | Haemonetics Corporation | 5.53B | -1.30% | 365,910 | 1.38B |
| 155 | LFST | LifeStance Health Group, Inc. | 5.51B | 2.84% | 3,734,170 | 1.68B |
| 156 | CON | Concentra Group Holdings Parent, Inc. | 5.50B | 2.09% | 572,902 | 2.34B |
| 157 | SRRK | Scholar Rock Holding Corporation | 5.43B | 3.08% | 2,663,182 | 570.00K |
| 158 | WAY | Waystar Holding Corp. | 5.41B | 0.43% | 1,024,923 | 1.26B |
| 159 | MANE | Veradermics, Incorporated | 5.40B | -1.24% | 487,688 | - |
| 160 | ERAS | Erasca, Inc. | 5.30B | -3.51% | 5,827,117 | - |
| 161 | MMED | MiniMed Group, Inc. | 5.25B | 3.67% | 10,719,687 | 3.22B |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.17B | -0.32% | 525,390 | 1.61B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.09B | -3.97% | 745,572 | 1.16B |
| 164 | LIVN | LivaNova PLC | 5.09B | 1.23% | 805,676 | 1.51B |
| 165 | LQDA | Liquidia Corporation | 5.08B | -1.81% | 1,875,169 | 621.87M |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 5.04B | -2.46% | 587,973 | 2.72M |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -4.90% | 1,279,798 | - |
| 168 | COGT | Cogent Biosciences, Inc. | 4.78B | -3.92% | 1,451,668 | - |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.77B | -1.88% | 1,189,537 | 651.03M |
| 170 | OPCH | Option Care Health, Inc. | 4.75B | 0.19% | 4,309,521 | 5.75B |
| 171 | GRAL | GRAIL, Inc. | 4.75B | -8.88% | 792,618 | 166.60M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.66B | -3.61% | 5,077,292 | 960.09M |
| 173 | SHC | Sotera Health Company | 4.64B | -2.17% | 3,137,968 | 1.23B |
| 174 | BLLN | BillionToOne, Inc. | 4.60B | -8.41% | 917,719 | 436.87M |
| 175 | ICUI | ICU Medical, Inc. | 4.55B | 1.45% | 366,980 | 2.18B |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.51B | -4.03% | 2,644,255 | 298.01M |
| 177 | HIMS | Hims & Hers Health, Inc. | 4.35B | -5.93% | 12,310,943 | 2.87B |
| 178 | ITGR | Integer Holdings Corporation | 4.32B | 0.21% | - | 1.83B |
| 179 | STVN | Stevanato Group S.p.A. | 4.24B | -1.71% | 1,083,259 | 1.42B |
| 180 | DFTX | Definium Therapeutics, Inc. | 4.13B | -5.99% | 1,131,559 | - |
| 181 | HTFL | HeartFlow, Inc. | 4.12B | -3.30% | 1,652,730 | 238.66M |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.10B | -5.22% | 1,581,265 | 53.81M |
| 183 | CRSP | CRISPR Therapeutics AG | 3.92B | -4.43% | 2,394,688 | 25.17M |
| 184 | TARS | Tarsus Pharmaceuticals, Inc. | 3.88B | -1.99% | 874,962 | 682.20M |
| 185 | CDNA | CareDx, Inc. | 3.87B | -5.34% | 1,032,500 | 497.40M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.86B | -3.01% | 1,104,811 | 7.50M |
| 187 | NVST | Envista Holdings Corporation | 3.85B | -1.88% | 2,328,525 | 2.88B |
| 188 | RLAY | Relay Therapeutics, Inc. | 3.82B | -4.53% | 1,651,500 | 10.35M |
| 189 | OGN | Organon & Co. | 3.65B | 0.00% | 3,534,067 | 6.10B |
| 190 | ABCL | AbCellera Biologics Inc. | 3.63B | -3.22% | 2,468,898 | 67.85M |
| 191 | ACHC | Acadia Healthcare Company, Inc. | 3.60B | 2.44% | 2,650,325 | 3.41B |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.57B | -8.22% | 1,578,180 | -665.00K |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.56B | 0.07% | 538,172 | 2.26M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.50B | -2.42% | 694,273 | - |
| 195 | IOVA | Iovance Biotherapeutics, Inc. | 3.49B | -2.71% | 8,428,134 | 378.98M |
| 196 | IRON | Disc Medicine, Inc. | 3.49B | -4.26% | 816,009 | - |
| 197 | SGRY | Surgery Partners, Inc. | 3.47B | -0.59% | 1,607,414 | 3.36B |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.43B | -3.93% | 1,701,586 | 508.68M |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.42B | -8.28% | 3,468,773 | - |
| 200 | PLSE | Pulse Biosciences, Inc. | 3.41B | -8.09% | 487,213 | 1.49M |
| 201 | VRDN | Viridian Therapeutics, Inc. | 3.38B | -3.47% | 2,094,723 | 26.31M |
| 202 | AXGN | Axogen, Inc. | 3.31B | -0.98% | 1,186,665 | 266.93M |
| 203 | WRBY | Warby Parker Inc. | 3.26B | -4.41% | 2,897,294 | 934.66M |
| 204 | NHC | National HealthCare Corporation | 3.25B | -0.36% | 92,173 | 1.58B |
| 205 | PRVA | Privia Health Group, Inc. | 3.23B | 2.89% | 1,556,983 | 2.43B |
| 206 | ACAD | Acadia Pharmaceuticals Inc. | 3.23B | -0.43% | 2,116,858 | 1.20B |
| 207 | TMDX | TransMedics Group, Inc. | 3.20B | 0.91% | 564,120 | 727.65M |
| 208 | BHC | Bausch Health Companies Inc. | 3.15B | 0.84% | 3,819,036 | 11.11B |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 3.13B | -0.18% | 369,777 | 1.46B |
| 210 | DYN | Dyne Therapeutics, Inc. | 3.13B | -2.68% | 1,849,633 | - |
| 211 | LEGN | Legend Biotech Corporation | 3.10B | -8.63% | 2,827,408 | 1.36B |
| 212 | TLX | Telix Pharmaceuticals Limited | 3.07B | -3.36% | 225,785 | 890.79M |
| 213 | IRTC | iRhythm Holdings, Inc. | 3.05B | -1.18% | 712,145 | 854.04M |
| 214 | XERS | Xeris Biopharma Holdings, Inc. | 3.05B | 0.24% | 2,678,036 | 368.26M |
| 215 | ADMA | ADMA Biologics, Inc. | 2.99B | -1.54% | 3,050,998 | 519.15M |
| 216 | CELC | Celcuity Inc. | 2.98B | -5.90% | 730,854 | - |
| 217 | IDYA | IDEAYA Biosciences, Inc. | 2.94B | -4.62% | 588,580 | 36.54M |
| 218 | VCEL | Vericel Corporation | 2.93B | 0.91% | 975,027 | 324.17M |
| 219 | DNLI | Denali Therapeutics Inc. | 2.90B | -3.52% | 1,146,872 | 21.38M |
| 220 | ATRC | AtriCure, Inc. | 2.82B | -2.69% | 560,829 | 589.80M |
| 221 | PGNY | Progyny, Inc. | 2.74B | 2.68% | 1,088,234 | 1.34B |
| 222 | XNCR | Xencor, Inc. | 2.66B | -4.56% | 1,033,600 | 200.49M |
| 223 | CLOV | Clover Health Investments, Corp. | 2.65B | -0.20% | 4,071,343 | 2.74B |
| 224 | ZLAB | Zai Lab Limited | 2.64B | -4.59% | 735,361 | 441.73M |
| 225 | MBX | MBX Biosciences, Inc. | 2.64B | -5.04% | 391,272 | - |
| 226 | HCM | HUTCHMED (China) Limited | 2.56B | -1.14% | 39,078 | 549.12M |
| 227 | ARDT | Ardent Health, Inc. | 2.55B | 1.69% | 744,962 | 6.45B |
| 228 | AVAH | Aveanna Healthcare Holdings Inc. | 2.54B | 1.13% | 2,254,018 | 2.68B |
| 229 | MD | Pediatrix Medical Group, Inc. | 2.43B | 1.88% | 394,540 | 1.96B |
| 230 | RCUS | Arcus Biosciences, Inc. | 2.43B | -3.27% | 1,082,635 | 100.00M |
| 231 | NEOG | Neogen Corporation | 2.38B | -3.12% | 2,387,458 | 884.00M |
| 232 | RGC | Regencell Bioscience Holdings Limited | 2.34B | -4.45% | 92,827 | - |
| 233 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -3.38% | 1,682,623 | 25.94M |
| 234 | UFPT | UFP Technologies, Inc. | 2.31B | -2.14% | 73,051 | 649.52M |
| 235 | PHVS | Pharvaris N.V. | 2.28B | -2.76% | 307,768 | - |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 3.92% | 531,104 | 1.17B |
| 237 | ADUS | Addus HomeCare Corporation | 2.27B | 1.31% | 171,174 | 1.50B |
| 238 | PRGO | Perrigo Company plc | 2.25B | -0.37% | 1,588,573 | 4.09B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.25B | -0.83% | 572,630 | 158.00K |
| 240 | LKFT | Lakefront Biotherapeutics NV | 2.20B | 2.38% | 292,620 | 1.13B |
| 241 | BKD | Brookdale Senior Living Inc. | 2.14B | -2.29% | 8,747,115 | 2.86B |
| 242 | ALMR | Alamar Biosciences, Inc. | 2.12B | -0.84% | 913,067 | 114.05M |
| 243 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -5.17% | 312,469 | - |
| 244 | BEAM | Beam Therapeutics Inc. | 2.09B | -8.28% | 3,332,610 | 146.64M |
| 245 | BHVN | Biohaven Ltd. | 2.08B | -0.14% | 1,765,298 | - |
| 246 | ESTA | Establishment Labs Holdings Inc. | 2.08B | -1.31% | 362,558 | 264.03M |
| 247 | IMNM | Immunome, Inc. | 2.08B | -6.18% | 1,519,236 | 4.02M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | -1.59% | 923,528 | 321.74M |
| 249 | SDGR | Schrödinger, Inc. | 2.05B | -7.35% | 1,198,177 | 269.20M |
| 250 | REPL | Replimune Group, Inc. | 2.03B | -2.19% | 2,033,229 | - |
| 251 | NEO | NeoGenomics, Inc. | 1.99B | -3.81% | 1,174,016 | 787.75M |
| 252 | TRLV | Trulieve Cannabis Corp. | 1.99B | -5.23% | 1,855,645 | 1.08B |
| 253 | SEPN | Septerna, Inc. | 1.98B | -2.18% | 385,337 | 96.27M |
| 254 | AZTA | Azenta, Inc. | 1.97B | 3.44% | 1,330,802 | 621.70M |
| 255 | AGL | agilon health, inc. | 1.96B | 0.94% | 199,963 | 6.00B |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 1.96B | -1.15% | 440,033 | - |
| 257 | VERA | Vera Therapeutics, Inc. | 1.95B | -4.02% | 1,003,937 | 10.28M |
| 258 | VCYT | Veracyte, Inc. | 1.94B | -1.32% | 2,319,346 | 581.78M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -2.37% | 710,506 | 989.36M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | -1.86% | 1,512,797 | 213.00M |
| 261 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.92B | -2.10% | 4,156,149 | 961.51M |
| 262 | FTRE | Fortrea Holdings Inc. | 1.91B | -2.03% | 1,117,771 | 2.67B |
| 263 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -2.64% | 1,665,347 | - |
| 264 | ZBIO | Zenas BioPharma, Inc. | 1.89B | -0.29% | 630,393 | 11.00M |
| 265 | MAZE | Maze Therapeutics, Inc. | 1.85B | -1.25% | 710,013 | 20.00M |
| 266 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | -0.08% | 613,534 | 141.06M |
| 267 | ZYME | Zymeworks Inc. | 1.83B | 0.80% | 969,740 | 265.97M |
| 268 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | -4.42% | 413,699 | - |
| 269 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | -8.79% | 19,788,026 | 68.23M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.80B | -4.56% | 540,853 | 140.84M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 1.77B | -2.35% | 3,391,247 | 3.58B |
| 272 | LMAT | LeMaitre Vascular, Inc. | 1.76B | -1.63% | 294,527 | 269.36M |
| 273 | WWB | Windward Bio Group AG | 1.74B | 5.40% | 237,397 | - |
| 274 | STOK | Stoke Therapeutics, Inc. | 1.74B | -0.19% | 581,586 | 28.21M |
| 275 | CERT | Certara, Inc. | 1.74B | -1.56% | 2,840,978 | 425.76M |
| 276 | INSP | Inspire Medical Systems, Inc. | 1.71B | -3.24% | 527,177 | 880.94M |
| 277 | ASTH | Astrana Health, Inc. | 1.68B | 3.36% | 453,773 | 3.91B |
| 278 | HCSG | Healthcare Services Group, Inc. | 1.68B | -0.16% | 462,619 | 1.88B |
| 279 | KMTS | Kestra Medical Technologies, Ltd. | 1.67B | -2.34% | 327,403 | 106.73M |
| 280 | MESO | Mesoblast Limited | 1.65B | -6.18% | 119,089 | 120.25M |
| 281 | LYCA | Lycia Therapeutics, Inc. | 1.65B | -8.30% | 250,870 | 4.44M |
| 282 | VIR | Vir Biotechnology, Inc. | 1.64B | -3.82% | 6,781,891 | 302.80M |
| 283 | KLRA | Kailera Therapeutics, Inc. | 1.63B | -5.28% | 962,782 | - |
| 284 | OMCL | Omnicell, Inc. | 1.63B | 1.17% | 445,783 | 1.24B |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.62B | -5.85% | 2,006,374 | 1.96B |
| 286 | RARE | Ultragenyx Pharmaceutical Inc. | 1.62B | -1.12% | 5,252,621 | 730.00M |
| 287 | ENOV | Enovis Corporation | 1.61B | 0.87% | 1,258,195 | 2.31B |
| 288 | NRIX | Nurix Therapeutics, Inc. | 1.61B | -4.84% | 2,156,608 | 701.94M |
| 289 | PSNL | Personalis, Inc. | 1.60B | -5.79% | 6,369,319 | 80.77M |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.59B | -0.30% | 620,213 | 593.56M |
| 291 | BRVE | Braveheart Bio, Inc. | 1.59B | -0.66% | 725,376 | - |
| 292 | TDOC | Teladoc Health, Inc. | 1.59B | -1.14% | 2,926,424 | 2.47B |
| 293 | ALVO | Alvotech | 1.57B | 5.13% | 1,027,644 | 492.31M |
| 294 | ALHC | Alignment Healthcare, Inc. | 1.56B | 1.49% | 3,387,368 | 4.94B |
| 295 | PGEN | Precigen, Inc. | 1.54B | -5.29% | 3,838,206 | 156.94M |
| 296 | QURE | uniQure N.V. | 1.53B | -8.11% | 1,010,467 | 20.17M |
| 297 | WGS | GeneDx Holdings Corp. | 1.53B | -2.58% | 1,009,440 | 460.78M |
| 298 | AMN | AMN Healthcare Services, Inc. | 1.53B | 4.26% | 935,337 | 3.52B |
| 299 | BFLY | Butterfly Network, Inc. | 1.53B | -6.09% | 4,036,704 | 123.26M |
| 300 | SLS | SELLAS Life Sciences Group, Inc. | 1.52B | -4.96% | 7,970,766 | - |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.50B | -0.77% | 254,028 | 1.04B |
| 302 | ADRX | ADARx Pharmaceuticals, Inc. | 1.50B | -1.41% | 667,015 | 6.13M |
| 303 | IMCR | Immunocore Holdings plc | 1.49B | -3.54% | 181,450 | 429.30M |
| 304 | KRSA | Korsana Biosciences, Inc. | 1.49B | 3.25% | 319,741 | - |
| 305 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 0.41% | 220,164 | 829.86M |
| 306 | RAPP | Rapport Therapeutics, Inc. | 1.47B | -5.09% | 462,817 | 20.00M |
| 307 | CNMD | CONMED Corporation | 1.47B | -2.45% | 390,276 | 1.37B |
| 308 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.05% | 1,805,740 | 743.30M |
| 309 | PAHC | Phibro Animal Health Corporation | 1.42B | -2.64% | 193,568 | 1.54B |
| 310 | LMRI | Lumexa Imaging Holdings, Inc. | 1.42B | -0.14% | 302,994 | 1.06B |
| 311 | DMRA | Damora Therapeutics, Inc. | 1.39B | 4.14% | 1,232,735 | - |
| 312 | LBRX | LB Pharmaceuticals Inc | 1.39B | -0.05% | 597,259 | - |
| 313 | NTLA | Intellia Therapeutics, Inc. | 1.38B | 1.65% | 6,611,185 | 52.89M |
| 314 | URGN | UroGen Pharma Ltd. | 1.38B | 7.33% | 3,982,620 | 250.25M |
| 315 | NBTX | Nanobiotix S.A. | 1.37B | -6.91% | 103,757 | 13.15M |
| 316 | TYRA | Tyra Biosciences, Inc. | 1.36B | -1.45% | 803,184 | - |
| 317 | ANAB | AnaptysBio, Inc. | 1.36B | -1.12% | 483,750 | 60.04M |
| 318 | NUVB | Nuvation Bio Inc. | 1.36B | -3.76% | 8,010,216 | 201.73M |
| 319 | PRCT | PROCEPT BioRobotics Corporation | 1.35B | -1.09% | 958,403 | 352.31M |
| 320 | GENB | Generate Biomedicines, Inc. | 1.35B | -13.09% | 1,318,181 | 21.07M |
| 321 | NVAX | Novavax, Inc. | 1.33B | -5.45% | 4,730,218 | 411.65M |
| 322 | GPCR | Structure Therapeutics Inc. | 1.33B | -7.15% | 762,979 | - |
| 323 | AVLN | Avalyn Pharma Inc. | 1.32B | -1.72% | 329,069 | - |
| 324 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | -0.98% | 3,384,009 | 5.49M |
| 325 | OCUL | Ocular Therapeutix, Inc. | 1.32B | -3.22% | 3,428,207 | 50.38M |
| 326 | NVCR | NovoCure Limited | 1.32B | -4.48% | 2,438,113 | 725.39M |
| 327 | INVA | Innoviva, Inc. | 1.31B | -2.84% | 814,095 | 438.32M |
| 328 | INNV | InnovAge Holding Corp. | 1.31B | 1.16% | 281,328 | 1.02B |
| 329 | STAA | STAAR Surgical Company | 1.31B | -1.44% | 568,054 | 328.27M |
| 330 | PNTG | The Pennant Group, Inc. | 1.30B | 2.66% | 498,445 | 1.17B |
| 331 | ABSI | Absci Corporation | 1.29B | -11.54% | 7,872,202 | 1.49M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.29B | -7.92% | 2,668,294 | 1.08B |
| 333 | GHRS | GH Research PLC | 1.29B | -1.83% | 644,007 | - |
| 334 | MLYS | Mineralys Therapeutics, Inc. | 1.29B | -5.22% | 1,116,102 | - |
| 335 | MNKD | MannKind Corporation | 1.27B | -4.24% | 2,794,563 | 413.37M |
| 336 | NKTR | Nektar Therapeutics | 1.25B | -2.23% | 842,470 | 52.19M |
| 337 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.24B | -0.68% | 541,664 | 745.79M |
| 338 | SLN | Silence Therapeutics plc | 1.23B | -0.15% | 625,458 | 456.00K |
| 339 | AAPG | Ascentage Pharma Group International | 1.22B | -9.10% | 12,764 | 94.61M |
| 340 | OMER | Omeros Corporation | 1.21B | -4.63% | 1,554,146 | 74.36M |
| 341 | OPK | OPKO Health, Inc. | 1.20B | -3.57% | 3,302,458 | 654.10M |
| 342 | KARD | Kardigan, Inc. | 1.20B | -7.02% | 395,703 | - |
| 343 | SVRA | Savara Inc. | 1.20B | -3.77% | 2,797,753 | - |
| 344 | CRON | Cronos Group Inc. | 1.20B | -3.25% | 943,639 | 206.20M |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.20B | -1.40% | 1,174,965 | 785.23M |
| 346 | CMPS | COMPASS Pathways plc | 1.17B | -8.21% | 3,278,017 | - |
| 347 | VOR | Vor Biopharma Inc. | 1.17B | -2.32% | 763,708 | - |
| 348 | NUTX | Nutex Health Inc. | 1.16B | -2.29% | 101,279 | 796.53M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.15B | -6.77% | 286,042 | 2.00M |
| 350 | AHG | Akso Health Group | 1.14B | 7.26% | 1,483 | 13.83M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -10.54% | 2,288,211 | - |
| 352 | HROW | Harrow, Inc. | 1.09B | -3.42% | 474,247 | 303.25M |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.09B | -8.19% | 789,244 | - |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.09B | -2.92% | 706,374 | 1.66B |
| 355 | IRMD | IRADIMED CORPORATION | 1.08B | -0.60% | 82,770 | 89.34M |
| 356 | FRNM | Freenome, Inc. | 1.08B | -3.07% | 993,588 | 217.86M |
| 357 | SGP | SpyGlass Pharma, Inc. | 1.08B | -1.95% | 246,130 | - |
| 358 | JBIO | Jade Biosciences, Inc. | 1.06B | -4.99% | 1,130,996 | - |
| 359 | GMRS | GMR Solutions Inc. | 1.06B | 1.56% | 1,487,529 | 5.97B |
| 360 | SIBN | SI-BONE, Inc. | 1.06B | -0.13% | 599,993 | 220.65M |
| 361 | ATEC | Alphatec Holdings, Inc. | 1.05B | -4.10% | 3,137,765 | 839.72M |
| 362 | AHCO | AdaptHealth Corp. | 1.03B | 0.91% | 2,029,126 | 3.44B |
| 363 | CBLL | CeriBell, Inc. | 1.03B | 1.07% | 770,439 | 108.72M |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.02B | -4.30% | 387,017 | - |
| 365 | CSTL | Castle Biosciences, Inc. | 1.01B | -3.08% | 652,285 | 377.13M |
| 366 | MLTX | MoonLake Immunotherapeutics | 998.30M | -6.16% | 1,396,045 | - |
| 367 | VSTM | Verastem, Inc. | 970.31M | -5.87% | 2,246,619 | 100.30M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 928.14M | 1.15% | 340,246 | 99.00K |
| 369 | AKTS | Aktis Oncology, Inc. | 901.69M | -2.77% | 597,517 | 12.39M |
| 370 | AORT | Artivion, Inc. | 901.15M | -3.30% | 523,787 | 481.88M |
| 371 | OMDA | Omada Health, Inc. | 898.93M | 1.12% | 1,639,639 | 333.04M |
| 372 | CRVS | Corvus Pharmaceuticals, Inc. | 894.14M | -0.38% | 751,024 | - |
| 373 | PHAR | Pharming Group N.V. | 891.25M | -0.08% | 10,483 | 386.75M |
| 374 | BVS | Bioventus Inc. | 881.37M | -1.88% | 381,576 | 585.64M |
| 375 | MGTX | MeiraGTx Holdings plc | 854.16M | -4.79% | 706,023 | 401.91M |
| 376 | HSTM | HealthStream, Inc. | 847.92M | -0.91% | 196,934 | 327.95M |
| 377 | CTY | City Therapeutics, Inc. | 844.87M | -6.19% | 238,264 | 14.34M |
| 378 | IMTX | Immatics N.V. | 843.38M | -3.44% | 762,157 | 49.33M |
| 379 | LTGO | Latigo Biotherapeutics, Inc. | 835.37M | -3.89% | 505,045 | - |
| 380 | BBNX | Beta Bionics, Inc. | 826.92M | -7.37% | 781,303 | 127.27M |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 823.43M | -1.64% | 148,594 | 288.21M |
| 382 | KIDS | OrthoPediatrics Corp. | 822.48M | -2.63% | 172,367 | 264.14M |
| 383 | SNDX | Syndax Pharmaceuticals, Inc. | 821.96M | -3.39% | 2,465,909 | 289.68M |
| 384 | IVA | Inventiva S.A. | 819.24M | -9.78% | 2,471,042 | 2.81M |
| 385 | BBTX | Bambusa Therapeutics, Inc. | 814.06M | -0.68% | 139,846 | - |
| 386 | IRWD | Ironwood Pharmaceuticals, Inc. | 802.92M | 0.41% | 3,109,429 | 400.30M |
| 387 | PHR | Phreesia, Inc. | 795.75M | 1.02% | 488,300 | 507.79M |
| 388 | COLL | Collegium Pharmaceutical, Inc. | 790.25M | 0.43% | 494,890 | 815.19M |
| 389 | GLUE | Monte Rosa Therapeutics, Inc. | 782.72M | -2.24% | 881,028 | 70.33M |
| 390 | ORIC | ORIC Pharmaceuticals, Inc. | 779.47M | -4.33% | 1,196,157 | - |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.16M | -2.23% | 1,482,062 | 38.54M |
| 392 | ARDX | Ardelyx, Inc. | 771.71M | -0.65% | 3,795,808 | 468.22M |
| 393 | VREX | Varex Imaging Corporation | 764.14M | 0.17% | 1,132,994 | 865.00M |
| 394 | OBX | Obsidian Therapeutics, Inc. | 763.51M | -1.59% | 727,802 | - |
| 395 | INMD | InMode Ltd. | 755.87M | -0.90% | 542,248 | 373.60M |
| 396 | AURA | Aura Biosciences, Inc. | 751.42M | 1.55% | 779,114 | - |
| 397 | PRME | Prime Medicine, Inc. | 747.70M | -1.87% | 6,738,841 | 7.06M |
| 398 | CTKB | Cytek Biosciences, Inc. | 736.31M | -3.60% | 1,141,579 | 207.65M |
| 399 | SLDB | Solid Biosciences Inc. | 723.24M | -5.26% | 872,565 | - |
| 400 | SGMT | Sagimet Biosciences Inc. | 722.96M | -0.88% | 1,024,198 | - |
| 401 | OABI | OmniAb, Inc. | 713.26M | -0.41% | 1,234,643 | 40.21M |
| 402 | QDEL | QuidelOrtho Corporation | 700.53M | -4.93% | 1,943,078 | 2.59B |
| 403 | DCTH | Delcath Systems, Inc. | 691.24M | -3.31% | 962,878 | 109.96M |
| 404 | ANNX | Annexon, Inc. | 681.03M | -8.93% | 3,114,492 | - |
| 405 | APMD | Apnimed, Inc. | 677.75M | -3.78% | 257,008 | 108.80M |
| 406 | FLGT | Fulgent Genetics, Inc. | 672.63M | -2.37% | 267,143 | 330.28M |
| 407 | ATTO | Attovia Therapeutics, Inc. | 672.21M | -2.68% | 171,493 | 1.44M |
| 408 | JANX | Janux Therapeutics, Inc. | 668.12M | -3.96% | 788,664 | 23.29M |
| 409 | ALMS | Alumis Inc. | 667.28M | -8.21% | 2,200,379 | 7.24M |
| 410 | QUIT | Achieve Life Sciences, Inc. | 666.81M | -4.11% | 822,495 | - |
| 411 | NVCT | Nuvectis Pharma, Inc. | 657.17M | -5.58% | 265,409 | - |
| 412 | KURA | Kura Oncology, Inc. | 651.42M | -8.75% | 2,630,498 | 79.31M |
| 413 | DBVT | DBV Technologies S.A. | 647.43M | -6.81% | 142,684 | 3.74M |
| 414 | BCAX | Bicara Therapeutics Inc. | 647.28M | -2.69% | 1,102,821 | - |
| 415 | ANL | Adlai Nortye Group Ltd. | 645.91M | -5.47% | 172,020 | 18.06M |
| 416 | OLMA | Olema Oncology, Inc. | 644.78M | -2.65% | 2,139,722 | - |
| 417 | SOPH | SOPHiA GENETICS SA | 637.30M | -9.38% | 782,480 | 90.97M |
| 418 | FDMT | 4D Molecular Therapeutics, Inc. | 636.52M | -7.69% | 968,930 | 96.06M |
| 419 | DSGN | Design Therapeutics, Inc. | 635.24M | -5.25% | 301,609 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 626.92M | -4.59% | 1,004,634 | - |
| 421 | ABUS | Arbutus Biopharma Corporation | 619.30M | -1.22% | 3,403,715 | 181.49M |
| 422 | CGEM | Cullinan Therapeutics, Inc. | 616.75M | -7.59% | 866,715 | - |
| 423 | SRZN | Surrozen, Inc. | 616.07M | 2.25% | 274,400 | 10.53M |
| 424 | GERN | Geron Corporation | 606.81M | -2.60% | 9,308,969 | 217.52M |
| 425 | AVBP | ArriVent BioPharma, Inc. | 597.92M | -11.15% | 644,237 | 5.00M |
| 426 | SENS | Senseonics Holdings, Inc. | 597.11M | 3.02% | 2,631,339 | 60.01M |
| 427 | TCMD | Tactile Systems Technology, Inc. | 590.72M | -1.64% | 145,291 | 356.42M |
| 428 | SGHT | Sight Sciences, Inc. | 588.58M | -2.22% | 189,200 | 88.40M |
| 429 | CLYM | Climb Bio, Inc. | 583.86M | -4.05% | 676,061 | - |
| 430 | CBIO | Crescent Biopharma, Inc. | 577.81M | -4.59% | 417,072 | 15.00M |
| 431 | PACB | Pacific Biosciences of California, Inc. | 575.79M | -6.12% | 14,412,301 | 161.39M |
| 432 | EVO | Evotec SE | 574.43M | -1.27% | 45,897 | 815.72M |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 571.80M | -8.04% | 9,950,115 | 6.40M |
| 434 | WVE | Wave Life Sciences, Inc. | 566.05M | -8.31% | 2,322,880 | 70.92M |
| 435 | SANA | Sana Biotechnology, Inc. | 563.31M | -6.93% | 4,351,517 | - |
| 436 | IAM | Iambic Therapeutics, Inc. | 561.70M | -9.54% | 457,253 | 18.25M |
| 437 | OBIO | Orchestra BioMed Holdings, Inc. | 560.38M | -1.79% | 755,585 | 31.21M |
| 438 | HELP | Helus Pharma Inc. | 560.37M | -13.53% | 12,843,527 | - |
| 439 | NRC | NRC Health | 558.76M | -0.87% | 103,698 | 143.79M |
| 440 | AVR | Anteris Technologies Global Corp. | 555.71M | 5.17% | 1,344,052 | 2.33M |
| 441 | DNA | Ginkgo Bioworks Holdings, Inc. | 550.95M | -11.55% | 3,407,512 | 130.75M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 550.42M | 1.87% | 1,761,713 | 147.76M |
| 443 | EVH | Evolent Health, Inc. | 546.30M | -1.43% | 1,261,014 | 2.34B |
| 444 | VALN | Valneva SE | 543.94M | -0.18% | 10,673 | 163.30M |
| 445 | MYGN | Myriad Genetics, Inc. | 534.29M | -1.59% | 1,117,320 | 803.60M |
| 446 | INDP | Indaptus Therapeutics, Inc. | 529.86M | 8.83% | 364,187 | - |
| 447 | ENTX | Entera Bio Ltd. | 525.90M | -2.89% | 208,543 | 42.00K |
| 448 | ETRA | Electra Therapeutics, Inc. | 521.59M | -6.00% | 394,876 | - |
| 449 | ANGO | AngioDynamics, Inc. | 495.40M | -0.76% | 298,555 | 325.38M |
| 450 | TKNO | Alpha Teknova, Inc. | 488.76M | -5.36% | 420,860 | 45.95M |
| 451 | MNPR | Monopar Therapeutics Inc. | 487.72M | -0.04% | 200,030 | - |
| 452 | EPRX | Eupraxia Pharmaceuticals Inc. | 486.40M | -9.94% | 705,389 | - |
| 453 | SRTA | Strata Critical Medical, Inc. | 484.11M | -1.63% | 915,756 | 280.76M |
| 454 | RGNX | REGENXBIO Inc. | 484.02M | -4.19% | 908,119 | 153.91M |
| 455 | CAPR | Capricor Therapeutics, Inc. | 482.58M | -12.91% | 3,919,851 | 11.13M |
| 456 | NGNE | Neurogene Inc. | 482.33M | -2.63% | 244,301 | 925.00K |
| 457 | RCEL | AVITA Medical, Inc. | 482.29M | -2.62% | 789,989 | 84.68M |
| 458 | GYRE | Gyre Therapeutics, Inc. | 480.49M | 1.86% | 577,140 | 110.06M |
| 459 | CARL | Carlsmed, Inc. | 475.46M | 1.34% | 191,020 | 71.78M |
| 460 | STTK | Shattuck Labs, Inc. | 474.59M | 0.22% | 1,337,963 | 1.00M |
| 461 | AQST | Aquestive Therapeutics, Inc. | 472.59M | -3.84% | 2,000,321 | 48.84M |
| 462 | KMDA | Kamada Ltd. | 471.50M | 0.25% | 116,214 | 196.87M |
| 463 | OCS | Oculis Holding AG | 471.02M | -0.13% | 211,164 | 1.12M |
| 464 | PHAT | Phathom Pharmaceuticals, Inc. | 467.05M | -2.97% | 1,118,057 | 274.88M |
| 465 | MDXG | MiMedx Group, Inc. | 464.04M | -0.93% | 1,487,580 | 303.73M |
| 466 | CADL | Candel Therapeutics, Inc. | 455.77M | -6.29% | 3,269,762 | - |
| 467 | OVID | Ovid Therapeutics Inc. | 452.96M | -5.51% | 2,796,913 | 1.45M |
| 468 | FENC | Fennec Pharmaceuticals Inc. | 450.49M | 9.81% | 793,190 | 66.37M |
| 469 | DMAC | DiaMedica Therapeutics Inc. | 449.47M | -5.23% | 246,370 | - |
| 470 | ARVN | Arvinas, Inc. | 443.33M | -0.73% | 1,318,402 | 275.30M |
| 471 | EOLS | Evolus, Inc. | 438.83M | -4.74% | 641,076 | 325.47M |
| 472 | MOBI | Mobia Medical, Inc. | 438.26M | -0.15% | 149,786 | 51.89M |
| 473 | ASMB | Assembly Biosciences, Inc. | 435.96M | 0.80% | 514,286 | 67.01M |
| 474 | BLSM | BlossomHill Therapeutics, Inc. | 433.86M | -2.64% | 98,608 | - |
| 475 | CTMX | CytomX Therapeutics, Inc. | 432.74M | -2.70% | 2,603,498 | 14.03M |
| 476 | SI | Shoulder Innovations, Inc. | 427.87M | -1.16% | 137,415 | 64.49M |
| 477 | CTEV | Claritev Corporation | 426.70M | -6.82% | 152,300 | 1.02B |
| 478 | AVTX | Avalo Therapeutics, Inc. | 426.16M | -5.03% | 1,116,528 | 59.00K |
| 479 | SLBT | SL Science Holding Limited | 410.31M | -1.03% | 35,887 | 3.27M |
| 480 | TECX | Tectonic Therapeutic, Inc. | 410.15M | -0.76% | 237,429 | - |
| 481 | PRTA | Prothena Corporation plc | 409.26M | -2.33% | 318,706 | 52.74M |
| 482 | IRD | Opus Genetics, Inc. | 390.48M | 1.51% | 975,299 | 7.91M |
| 483 | RLMD | Relmada Therapeutics, Inc. | 385.17M | -14.25% | 2,418,880 | - |
| 484 | MPLT | MapLight Therapeutics, Inc. | 383.47M | -4.83% | 305,244 | - |
| 485 | CRMD | CorMedix Inc. | 383.37M | 3.43% | 3,196,767 | 412.49M |
| 486 | ALEC | Alector, Inc. | 382.61M | 1.18% | 2,769,731 | 173.47M |
| 487 | BWAY | BrainsWay Ltd. | 382.24M | -7.12% | 207,561 | 60.70M |
| 488 | MASS | 908 Devices Inc. | 382.14M | -5.65% | 418,369 | 65.79M |
| 489 | CTNM | Contineum Therapeutics, Inc. | 379.70M | -1.93% | 348,145 | - |
| 490 | PBYI | Puma Biotechnology, Inc. | 379.47M | -5.53% | 548,858 | 231.83M |
| 491 | CERS | Cerus Corporation | 375.63M | -6.30% | 2,594,636 | 226.57M |
| 492 | RZLT | Rezolute, Inc. | 375.55M | -2.05% | 4,180,382 | - |
| 493 | STLN | Starling Oncology, Inc. | 361.05M | 1.14% | 7,246,714 | 620.45M |
| 494 | SPRY | ARS Pharmaceuticals, Inc. | 360.90M | -7.71% | 3,284,813 | 122.14M |
| 495 | LYEL | Lyell Immunopharma, Inc. | 360.18M | 2.45% | 345,037 | 15.00K |
| 496 | ASPE | Aspen Neuroscience, Inc. | 355.63M | -2.86% | 216,303 | - |
| 497 | EMBC | Embecta Corp. | 354.12M | -3.25% | 947,825 | 1.02B |
| 498 | PRLD | Prelude Therapeutics Incorporated | 352.12M | -1.16% | 306,850 | 21.57M |
| 499 | CCCC | C4 Therapeutics, Inc. | 347.99M | -3.99% | 3,106,063 | 32.28M |
| 500 | CV | CapsoVision, Inc. | 346.85M | 7.30% | 170,080 | 13.92M |